Latest Articles

Publication Date
Japan rejoice in Macao as Hayata, Hashimoto and Togami advance to second round - Adelaide Now

Japan rejoice in Macao as Hayata, Hashimoto and Togami advance to second round Adelaide Now

Published: Sept. 10, 2026, 7:43 a.m.
A new saliva test for endometriosis is in trials - Japan Today

A new saliva test for endometriosis is in trials Japan Today

Published: Aug. 31, 2026, 8:05 p.m.
A new saliva test for endometriosis is in trials - japantoday.com

A new saliva test for endometriosis is in trials japantoday.com

Published: Aug. 31, 2026, 8:05 p.m.
Charli XCX - Japan 1975 (1nkqgLtYtx) - Mshale

Charli XCX - Japan 1975 (1nkqgLtYtx) Mshale

Published: Aug. 13, 2026, 8:52 a.m.
N.Y. Doctor Sentenced in Japan for Vandalizing Ancient Religious Sites - The New York Times

N.Y. Doctor Sentenced in Japan for Vandalizing Ancient Religious Sites The New York Times

Published: Aug. 6, 2026, 7:26 p.m.
Cartherics secures Japanese patent to bolster cell therapy push - Biotech Dispatch

Cartherics secures Japanese patent to bolster cell therapy push Biotech Dispatch

Published: June 11, 2026, 1:50 a.m.
Cartherics secures Japanese patent to bolster cell therapy push - PharmaDispatch

Cartherics secures Japanese patent to bolster cell therapy push PharmaDispatch

Published: June 10, 2026, 12:17 a.m.
LG Chem Licenses Japan's Top Endometriosis Drug to Expand Women's Health Business - Seoul Economic Daily

LG Chem Licenses Japan's Top Endometriosis Drug to Expand Women's Health Business Seoul Economic Daily

Published: April 3, 2026, 2:09 a.m.
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제

LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제

Published: April 2, 2026, 11:40 p.m.
Kissei Pharmaceutical Aktie surges on Icelty launch for uterine fibroids in Japan - AD HOC NEWS

Kissei Pharmaceutical Aktie surges on Icelty launch for uterine fibroids in Japan AD HOC NEWS

Published: March 20, 2026, 5:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!